Lawrence A. Kenyon
Chief Financial Officer, NEOPHARM INC.
Companies
- Outlook Therapeutics, Inc.Board member Aug 3, 2018 to now1
- Outlook Therapeutics, Inc.Chief financial officer May 12, 2016 to Sep 2, 20262
- Outlook Therapeutics, Inc.Chief executive officer Aug 3, 2018 to Apr 20, 20211
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Outlook Therapeutics, Inc. OTLK106,956 shares3$53.5K at $0.50Aug 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 14, 2026Bought 101,010 shares of Outlook Therapeutics, Inc.3
- Sep 26, 2024Bought 5,000 shares at $5.69 of Outlook Therapeutics, Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Sep 30, 2024